NEW DELHI: The company claimed that the vaccine, manufactured by the US-based multinational pharmaceutical company Phase, was completed yesterday, with a 75 percent effectiveness. “If all goes well, the vaccine will be distributed by Christmas,” said Uigur Sachin, chief executive of Biotechnology. “If everything goes well, I hope that in the second half of December, we will get emergency leave from the U.S. government and start distributing it before Christmas,” he said. Uigur Sachin, the chief executive of BioNetech4, said in a statement that the vaccine, which was developed jointly by Fischer ‘and’ BioNetech4 ‘, was 75% effective in preventing the infection of Covid9-18. Done It has a positive effect on all types of coronary heart disease and has no major side effects The vaccine has been shown to be 7% effective, especially in the body of patients over the age of 45 years According to the final phase report, the vaccine could be widely used around the world. The company said it plans to apply for emergency leave from the U.S. government when the results come out.
